Transformation of mouse fibroblasts with the oncogenes H-ras ortrk is associated with pronounced changes in drug sensitivity and metabolism

This publication has 23 references indexed in Scilit:

• Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
  European Journal of Cancer and Clinical Oncology, 1991
• The trk proto-oncogene encodes a receptor for nerve growth factor
  Cell, 1991
• Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes
  British Journal of Cancer, 1991
• Activation and cytotoxicity of 5′-deoxy-5-fluorouridine in c-H-ras transformed NIH 3T3 cells
  Biochemical Pharmacology, 1991
• Mechanisms involved in the development of adriamycin resistance in human leukemic cells
  Leukemia Research, 1990
• Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes
  British Journal of Cancer, 1989
• Molecular and biochemical characterization of the human trk proto-oncogene.
  Molecular and Cellular Biology, 1989
• A sensitive non-radioactive assay for pyrimidine nucleoside phosphorylase using reversed-phase high performance liquid chromatography
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1988
• Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.
  Proceedings of the National Academy of Sciences, 1987
• Oncogenes
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986